← Back to Bills
S 5103118th CongressFailed / ExpiredSenate

Food and Drug Administration Foods Accountability Act

Policy Area: Health
View on Congress.gov
Origin Chamber
Senate
Last Updated
Apr 21, 2025
Latest Action Date
Sep 19, 2024

Latest Action

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Food and Drug Administration Foods Accountability Act (S.5103) was a Senate bill introduced in the 118th Congress aimed at enhancing accountability within the FDA's oversight of foods. The bill was referred to the Committee on Health, Education, Labor, and Pensions but did not advance further and ultimately failed or expired. No official summary or full text is available, limiting detailed analysis of its specific provisions or mechanisms.

Bottom Line

S.5103 sought to improve FDA accountability regarding food regulation but did not progress beyond committee referral and expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill was introduced in the Senate during the 118th Congress and referred to the Health, Education, Labor, and Pensions Committee.
  • Its policy area is health, specifically focusing on FDA oversight of foods.
  • The bill status is marked as failed or expired, indicating no legislative action beyond referral.
Who Benefits?

['Food consumers who rely on FDA oversight for food safety and quality.', 'The Food and Drug Administration as the regulatory body potentially subject to enhanced accountability measures.', 'Food industry stakeholders who interact with FDA regulations.']

Potential Concerns

['Lack of available text and summary limits understanding of implementation requirements and costs.', 'Unclear if the bill would have expanded FDA authority or oversight mechanisms, which could affect regulatory burden.', 'Potential tradeoffs between increased accountability and resource allocation within the FDA.']

Political Context

The bill was introduced in the Senate and referred to a relevant committee but did not advance, reflecting either limited legislative priority or competing policy interests during the 118th Congress. No further legislative actions were recorded.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['If enacted, the bill could have influenced FDA operational procedures and accountability frameworks, potentially affecting food safety enforcement and industry compliance.', 'Failure to pass maintains the status quo in FDA food oversight, possibly delaying reforms or improvements in accountability.']

GovScope Watchdog Notes

The absence of an official summary and full text restricts transparency and public understanding of the bill's intended changes. Monitoring legislative progress and availability of detailed texts is essential for effective oversight and informed public discourse.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready